Xiamen Amoytop Biotech Co Ltd (688278) — Financial Flexibility Index
Xiamen Amoytop Biotech Co Ltd (688278) has a Financial Flexibility Index of 0.84x as of September 2023. Free cash flow of CN¥375.30 Million (operating CF CN¥332.29 Million minus capex CN¥43.00 Million) represents 1% of total liabilities (CN¥447.44 Million). Check Xiamen Amoytop Biotech Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xiamen Amoytop Biotech Co Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Xiamen Amoytop Biotech Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Xiamen Amoytop Biotech Co Ltd generate cash.
Annual Financial Flexibility Index for Xiamen Amoytop Biotech Co Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Xiamen Amoytop Biotech Co Ltd. Explore Xiamen Amoytop Biotech Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.37x | CN¥681.99 Million | CN¥430.63 Million | CN¥497.10 Million | ▼ -13.0% |
| 2023 | 1.58x | CN¥756.58 Million | CN¥512.10 Million | CN¥479.69 Million | ▼ -2.2% |
| 2022 | 1.61x | CN¥582.33 Million | CN¥363.16 Million | CN¥360.96 Million | ▼ -0.4% |
| 2021 | 1.62x | CN¥425.71 Million | CN¥234.78 Million | CN¥262.91 Million | ▲ +47.3% |
| 2020 | 1.10x | CN¥211.42 Million | CN¥92.61 Million | CN¥192.33 Million | ▲ +47.9% |
| 2019 | 0.74x | CN¥168.13 Million | CN¥123.30 Million | CN¥226.27 Million | ▲ +49.3% |
| 2018 | 0.50x | CN¥103.75 Million | CN¥89.15 Million | CN¥208.51 Million | ▲ +394.4% |
| 2017 | 0.10x | CN¥15.49 Million | CN¥-11.41 Million | CN¥153.86 Million | ▼ -87.2% |
| 2016 | 0.79x | CN¥129.46 Million | CN¥42.43 Million | CN¥164.49 Million | — |